Identification of CHEK2 Germline Mutations in BRCA1/2- and PALB2-Negative Breast and Ovarian Cancer Patients

被引:1
作者
Aksoy, Fuat [1 ]
Tezcan Unlu, Havva [2 ]
Cecener, Gulsah [2 ]
Guney Eskiler, Gamze [3 ]
Egeli, Unal [2 ]
Tunca, Berrin [2 ]
Efendi Erdem, Ecem [2 ]
Senol, Kazim [1 ]
Gokgoz, Mustafa Sehsuvar [1 ]
机构
[1] Bursa Uludag Univ, Fac Med, Dept Gen Surg, Bursa, Turkey
[2] Bursa Uludag Univ, Fac Med, Dept Med Biol, Bursa, Turkey
[3] Sakarya Univ, Fac Med, Dept Med Biol, Sakarya, Turkey
关键词
CHEK2; gene; Early-onset breast cancer; c.1103A > G; Variant of uncertain significance; GENETIC VARIANT; RISK; CLASSIFICATION; 1100DELC; ALLELE; WOMEN;
D O I
10.1159/000521369
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: The CHEK2 gene is known to be an important signal transducer involved in DNA repair, apoptosis, or cell cycle arrest in response to DNA damage. The mutations in this gene have been associated with a wide range of cancers, both sporadic and hereditary. Germline CHEK2 mutations are linked to an increased risk of breast cancer. Therefore, the aim of this study was to identify the prevalence of CHEK2 variants in BRCA1/2- and PALB2-negative early-onset patients with breast cancer and/or ovarian cancer in a Turkish population for the first time. Methods: The study included 95 patients with BRCA1/2- and PALB2-negative early-onset breast cancer and/or ovarian cancer and also 60 unaffected women. All the intron/exon boundaries and coding exons of CHEK2 were subjected to mutational analysis by heteroduplex analysis and DNA sequencing. Results: A total of 16 CHEK2 variants were found in breast cancer patients within the Turkish population. CHEK2 c.1100delC mutation most frequently studied in the CHEK2 gene was not detected in our study. The prevalence of variants of uncertain significance in CHEK2 was found to be 7.3% (n = 7) in BRCA1/2 and PALB2 mutation-negative Turkish patients with early-onset breast and/or ovarian cancer. Conclusion: The present study may shed light on alternative variations that could be significant for understanding the prevalence and clinical suitability of the CHEK2 gene.
引用
收藏
页码:21 / 33
页数:13
相关论文
共 33 条
  • [1] CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
    Adank, Muriel A.
    Jonker, Marianne A.
    Kluijt, Irma
    van Mil, Saskia E.
    Oldenburg, Rogier A.
    Mooi, Wolter J.
    Hogervorst, Frans B. L.
    van den Ouweland, Ans M. W.
    Gille, Johan J. P.
    Schmidt, Marjanka K.
    van der Vaart, Aad W.
    Meijers-Heijboer, Hanne
    Waisfisz, Quinten
    [J]. JOURNAL OF MEDICAL GENETICS, 2011, 48 (12) : 860 - 863
  • [2] CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases
    Apostolou, Paraskevi
    Fostira, Florentia
    Papamentzelopoulou, Myrto
    Michelli, Maria
    Panopoulos, Christos
    Fountzilas, George
    Konstantopoulou, Irene
    Voutsinas, Gerassimos E.
    Yannoukakos, Drakoulis
    [J]. CANCER GENETICS, 2015, 208 (04) : 129 - 134
  • [3] Hereditary Breast Cancer: The Era of New Susceptibility Genes
    Apostolou, Paraskevi
    Fostira, Florentia
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [4] Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
    Byrnes, Graham B.
    Southey, Melissa C.
    Hopper, John L.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (03)
  • [5] Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
    Cai, Zhenjian
    Chehab, Nabil H.
    Pavletich, Nikola P.
    [J]. MOLECULAR CELL, 2009, 35 (06) : 818 - 829
  • [6] Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey
    Cecener, G.
    Eskiler, G. Guney
    Egeli, U.
    Tunca, B.
    Alemdar, A.
    Gokgoz, S.
    Tasdelen, I.
    [J]. MOLECULAR BIOLOGY REPORTS, 2016, 43 (11) : 1273 - 1284
  • [7] BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients
    Cecener, Gulsah
    Egeli, Unal
    Tunca, Berrin
    Erturk, Elif
    Ak, Secil
    Gokgoz, Sehsuvar
    Tasdelen, Ismet
    Tezcan, Gulcin
    Demirdogen, Elif
    Bayram, Nuran
    Avci, Nilufer
    Evrensel, Turkkan
    [J]. CANCER INVESTIGATION, 2014, 32 (08) : 375 - 387
  • [8] Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
    Cybulski, Cezary
    Wokolorczyk, Dominika
    Jakubowska, Anna
    Huzarski, Tomasz
    Byrski, Tomasz
    Gronwald, Jacek
    Masojc, Bartlomiej
    Debniak, Tadeusz
    Gorski, Bohdan
    Blecharz, Pawel
    Narod, Steven A.
    Lubinski, Jan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) : 3747 - 3752
  • [9] CHEK2 contribution to hereditary breast cancer in non-BRCA families
    Desrichard, Alexis
    Bidet, Yannick
    Uhrhammer, Nancy
    Bignon, Yves-Jean
    [J]. BREAST CANCER RESEARCH, 2011, 13 (06):
  • [10] Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives
    Egeli, Unal
    Cecener, Gulsah
    Tunca, Berrin
    Tasdelen, Ismet
    [J]. CANCER INVESTIGATION, 2006, 24 (05) : 484 - 491